These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Serotonin syndrome after administration of milnacipran for fibromyalgia. Yacoub HA; Johnson WG; Souayah N Neurology; 2010 Feb; 74(8):699-700. PubMed ID: 20177126 [No Abstract] [Full Text] [Related]
3. Serotonin syndrome after a single dose of fluvoxamine. Mullins ME; Horowitz BZ Ann Emerg Med; 1999 Dec; 34(6):806-7. PubMed ID: 10577418 [No Abstract] [Full Text] [Related]
4. Differential effects of milnacipran, fluvoxamine and paroxetine for depression, especially in gender. Morishita S; Arita S Eur Psychiatry; 2003 Dec; 18(8):418-20. PubMed ID: 14680720 [No Abstract] [Full Text] [Related]
5. [Serotonin syndrome secondary to the use of sertraline and metoclopramide]. Vandemergel X; Beukinga I; Nève P Rev Med Brux; 2000 Jun; 21(3):161-3. PubMed ID: 10925598 [TBL] [Abstract][Full Text] [Related]
6. Serotonin Syndrome: Difficult to Diagnose but Critical to Treat. Raguveer V; Varshney A; D'Ambrosio JC Del Med J; 2015 Nov; 87(11):342-4. PubMed ID: 26731887 [No Abstract] [Full Text] [Related]
7. First time, low dose citalopram use-related serotonin syndrome. Turedi S; Eraydin I; Gunduz A; Kalkan A; Hos U Neurotoxicology; 2007 Nov; 28(6):1272-4. PubMed ID: 18213744 [TBL] [Abstract][Full Text] [Related]
8. Possible interaction between milnacipran and warfarin potassium. Sawamura J; Kozaki K; Mochizuki S; Ishigooka J J Clin Pharmacol; 2012 May; 52(5):780-1. PubMed ID: 22539653 [No Abstract] [Full Text] [Related]
9. Post-treatment emergent adverse events in depressed patients following treatment with milnacipran and paroxetine. Vandel P; Sechter D; Weiller E; Pezous N; Cabanac F; Tournoux A; Panconi E Hum Psychopharmacol; 2004 Dec; 19(8):585-6. PubMed ID: 15570574 [No Abstract] [Full Text] [Related]
10. Venlafaxine-induced serotonin syndrome with relapse following amitriptyline. Perry NK Postgrad Med J; 2000 Apr; 76(894):254-6. PubMed ID: 10727586 [TBL] [Abstract][Full Text] [Related]
11. Milnacipran and selective serotonin reuptake inhibitors in major depression. Lopez-Ibor J; Guelfi JD; Pletan Y; Tournoux A; Prost JF Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():41-6. PubMed ID: 8923126 [TBL] [Abstract][Full Text] [Related]
13. [Probable Serotonin Syndrome and Withdrawal Symptoms Caused by Milnacipran]. Koshiishi T; Okuyama K Yakugaku Zasshi; 2016; 136(12):1675-1679. PubMed ID: 27904101 [TBL] [Abstract][Full Text] [Related]
14. Clinical potential of milnacipran, a serotonin and norepinephrine reuptake inhibitor, in pain. Leo RJ; Brooks VL Curr Opin Investig Drugs; 2006 Jul; 7(7):637-42. PubMed ID: 16869117 [TBL] [Abstract][Full Text] [Related]
15. Sertraline-induced serotonin syndrome followed by mirtazapine reaction. Butler MC; Di Battista M; Warden M Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1128-9. PubMed ID: 20430060 [No Abstract] [Full Text] [Related]
16. Concomitant triptan and SSRI or SNRI use: what is the risk for serotonin syndrome? Evans RW Headache; 2008 Apr; 48(4):639-40. PubMed ID: 18377388 [No Abstract] [Full Text] [Related]
17. Serotonin syndrome induced by fluvoxamine and mirtazapine. Demers JC; Malone M Ann Pharmacother; 2001 Oct; 35(10):1217-20. PubMed ID: 11675850 [TBL] [Abstract][Full Text] [Related]
18. [Adverse effects of antidepressants and antimanics]. Tanaka T; Koyama T Ryoikibetsu Shokogun Shirizu; 2003; (38):362-5. PubMed ID: 12877003 [No Abstract] [Full Text] [Related]
20. Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerability. Puech A; Montgomery SA; Prost JF; Solles A; Briley M Int Clin Psychopharmacol; 1997 Mar; 12(2):99-108. PubMed ID: 9219045 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]